Ernesto Vigna

1.6k total citations
85 papers, 649 citations indexed

About

Ernesto Vigna is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Ernesto Vigna has authored 85 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Hematology, 36 papers in Genetics and 34 papers in Molecular Biology. Recurrent topics in Ernesto Vigna's work include Multiple Myeloma Research and Treatments (26 papers), Chronic Lymphocytic Leukemia Research (24 papers) and Protein Degradation and Inhibitors (18 papers). Ernesto Vigna is often cited by papers focused on Multiple Myeloma Research and Treatments (26 papers), Chronic Lymphocytic Leukemia Research (24 papers) and Protein Degradation and Inhibitors (18 papers). Ernesto Vigna collaborates with scholars based in Italy, United States and Spain. Ernesto Vigna's co-authors include Massimo Gentile, Fortunato Morabito, Anna Grazia Recchia, Francesco Mendicino, Eugenio Lucia, Lucio Morabito, Enrica Antonia Martino, Antonino Neri, Anna Grazia Recchia and Carla Mazzone and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and British Journal of Haematology.

In The Last Decade

Ernesto Vigna

77 papers receiving 635 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ernesto Vigna Italy 15 316 296 193 178 107 85 649
Matteo Molica Italy 16 487 1.5× 253 0.9× 163 0.8× 341 1.9× 82 0.8× 70 773
Abelardo Bárez Spain 17 513 1.6× 386 1.3× 226 1.2× 309 1.7× 156 1.5× 42 918
Florence Hourcade‐Potelleret Switzerland 16 183 0.6× 130 0.4× 195 1.0× 223 1.3× 74 0.7× 27 567
Nishant Tageja United States 15 212 0.7× 188 0.6× 163 0.8× 115 0.6× 46 0.4× 33 516
Betty Glinsmann‐Gibson United States 15 409 1.3× 422 1.4× 272 1.4× 146 0.8× 111 1.0× 23 853
Melissa Ooi Singapore 15 409 1.3× 589 2.0× 280 1.5× 89 0.5× 73 0.7× 75 848
Mohammad R. Nowrousian Germany 15 359 1.1× 245 0.8× 237 1.2× 114 0.6× 63 0.6× 31 693
Naresh Punwani United States 12 268 0.8× 178 0.6× 241 1.2× 288 1.6× 224 2.1× 17 803
Sonja Mandl–Weber Germany 16 241 0.8× 511 1.7× 225 1.2× 117 0.7× 77 0.7× 26 921
Laurie Gashin United States 6 121 0.4× 148 0.5× 209 1.1× 100 0.6× 95 0.9× 9 527

Countries citing papers authored by Ernesto Vigna

Since Specialization
Citations

This map shows the geographic impact of Ernesto Vigna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ernesto Vigna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ernesto Vigna more than expected).

Fields of papers citing papers by Ernesto Vigna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ernesto Vigna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ernesto Vigna. The network helps show where Ernesto Vigna may publish in the future.

Co-authorship network of co-authors of Ernesto Vigna

This figure shows the co-authorship network connecting the top 25 collaborators of Ernesto Vigna. A scholar is included among the top collaborators of Ernesto Vigna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ernesto Vigna. Ernesto Vigna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bruzzese, Antonella, Ernesto Vigna, Enrica Antonia Martino, et al.. (2025). TP53 ‐Mutated Acute Myeloid Leukemia: Unanswered Questions. Hematological Oncology. 43(4). e70106–e70106.
2.
Martino, Enrica Antonia, Danilo Lofaro, Francesco Mendicino, et al.. (2025). A network meta-analysis of randomized clinical trials in lenalidomide-exposed or -refractory multiple myeloma patients. ESMO Open. 10(8). 105514–105514. 1 indexed citations
3.
Bruzzese, Antonella, Enrica Antonia Martino, Francesco Mendicino, et al.. (2025). Therapeutic Strategies for Relapsed or Refractory B‐Cell Acute Lymphoblastic Leukemia in Adult Patients: Optimizing the Use of Monoclonal Antibodies. European Journal Of Haematology. 114(6). 938–952. 2 indexed citations
4.
Vigna, Ernesto, Antonella Bruzzese, Nicola Amodio, et al.. (2025). Bruton Tyrosine Kinase Inhibitors in Mantle Cell Lymphoma: What Are the Current Options?. European Journal Of Haematology. 115(6). 599–609.
5.
Bruzzese, Antonella, Enrica Antonia Martino, Francesco Mendicino, et al.. (2024). Myelodysplastic syndromes del(5q): Pathogenesis and its therapeutic implications. European Journal Of Haematology. 112(6). 860–869.
6.
Martino, Enrica Antonia, Ernesto Vigna, Antonella Bruzzese, et al.. (2024). Talquetamab in Multiple Myeloma: Efficacy, Safety, and Future Directions. European Journal Of Haematology. 114(3). 386–399. 5 indexed citations
7.
Bruzzese, Antonella, Ernesto Vigna, Enrica Antonia Martino, et al.. (2023). Myelodysplastic syndromes with ring sideroblasts. Hematological Oncology. 41(4). 612–620. 1 indexed citations
8.
Bruzzese, Antonella, Enrica Antonia Martino, Francesco Mendicino, et al.. (2023). Tagraxofusp in myeloid malignancies. Hematological Oncology. 42(1). e3234–e3234. 2 indexed citations
9.
Bruzzese, Antonella, Ernesto Vigna, Enrica Antonia Martino, et al.. (2023). Safe and Effective Administration of Caplacizumab in COVID-19-Associated Thrombotic Thrombocytopenic Purpura. SHILAP Revista de lepidopterología. 15(3). 448–453.
10.
Martino, Enrica Antonia, Antonella Bruzzese, Francesco Mendicino, et al.. (2023). Teclistamab‐cqyv in multiple myeloma. European Journal Of Haematology. 112(3). 320–327. 11 indexed citations
11.
Morabito, Fortunato, Giovanni Tripepi, Enrica Antonia Martino, et al.. (2021). Spotlight on Melphalan Flufenamide: An Up-and-Coming Therapy for the Treatment of Myeloma. Drug Design Development and Therapy. Volume 15. 2969–2978. 12 indexed citations
12.
Botta, Cirino, Francesco Mendicino, Enrica Antonia Martino, et al.. (2021). Mechanisms of Immune Evasion in Multiple Myeloma: Open Questions and Therapeutic Opportunities. Cancers. 13(13). 3213–3213. 23 indexed citations
13.
Gentile, Massimo, Fortunato Morabito, Massimo Martino, et al.. (2021). Chemotherapy-based regimens in multiple myeloma in 2020. Panminerva Medica. 63(1). 7–12. 12 indexed citations
14.
Morabito, Fortunato, Anna Grazia Recchia, Ernesto Vigna, et al.. (2019). An in-depth evaluation of acalabrutinib for the treatment of mantle-cell lymphoma. Expert Opinion on Pharmacotherapy. 21(1). 29–38. 3 indexed citations
15.
Vigna, Ernesto, Annamaria Petrungaro, Anna Perri, et al.. (2018). Efficacy of eculizumab in severe ADAMTS13-deficient thrombotic thrombocytopenic purpura (TTP) refractory to standard therapies. Transfusion and Apheresis Science. 57(2). 247–249. 13 indexed citations
16.
Gentile, Massimo, Annamaria Petrungaro, Giuseppina Uccello, et al.. (2017). Venetoclax for the treatment of chronic lymphocytic leukemia. Expert Opinion on Investigational Drugs. 26(11). 1307–1316. 42 indexed citations
17.
Martino, Massimo, Anna Grazia Recchia, Giuseppe Console, et al.. (2017). Can we improve the conditioning regimen before autologous stem cell transplantation in multiple myeloma?. Expert Opinion on Orphan Drugs. 5(11). 875–887. 3 indexed citations
18.
Martino, Massimo, Mercedes Gori, Annalisa Pitino, et al.. (2017). Basal CD34+ Cell Count Predicts Peripheral Blood Stem Cell Mobilization in Healthy Donors after Administration of Granulocyte Colony–Stimulating Factor: A Longitudinal, Prospective, Observational, Single-Center, Cohort Study. Biology of Blood and Marrow Transplantation. 23(7). 1215–1220. 14 indexed citations
19.
Gentile, Massimo, Anna Grazia Recchia, Carla Mazzone, et al.. (2013). An old drug with a new future: bendamustine in multiple myeloma. Expert Opinion on Pharmacotherapy. 14(16). 2263–2280. 12 indexed citations
20.
Vigna, Ernesto, Eugenio Lucia, Massimo Gentile, et al.. (2007). PDGFRalpha/FIP1L1-positive chronic eosinophilic leukemia presenting with retro-orbital localization: efficacy of imatinib treatment. Cancer Chemotherapy and Pharmacology. 61(4). 713–716. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matteo Molica Breakdown of academic impact, for papers by Abelardo Bárez Breakdown of academic impact, for papers by Florence Hourcade‐Potelleret Breakdown of academic impact, for papers by Nishant Tageja Breakdown of academic impact, for papers by Betty Glinsmann‐Gibson Breakdown of academic impact, for papers by Melissa Ooi Breakdown of academic impact, for papers by Mohammad R. Nowrousian Breakdown of academic impact, for papers by Naresh Punwani Breakdown of academic impact, for papers by Sonja Mandl–Weber Breakdown of academic impact, for papers by Laurie Gashin
Rankless by CCL
2026